134 related articles for article (PubMed ID: 14600207)
1. Chimeric ribonuclease as a source of human adapter protein for targeted drug delivery.
Gaynutdinov TI; Myshkin E; Backer JM; Backer MV
Protein Eng; 2003 Oct; 16(10):771-5. PubMed ID: 14600207
[TBL] [Abstract][Full Text] [Related]
2. Adapter protein for site-specific conjugation of payloads for targeted drug delivery.
Backer MV; Gaynutdinov TI; Patel V; Jehning BT; Myshkin E; Backer JM
Bioconjug Chem; 2004; 15(5):1021-9. PubMed ID: 15366955
[TBL] [Abstract][Full Text] [Related]
3. Humanized docking system for assembly of targeting drug delivery complexes.
Backer MV; Gaynutdinov TI; Gorshkova II; Crouch RJ; Hu T; Aloise R; Arab M; Przekop K; Backer JM
J Control Release; 2003 May; 89(3):499-511. PubMed ID: 12737851
[TBL] [Abstract][Full Text] [Related]
4. Engineering S-protein fragments of bovine ribonuclease A for targeted drug delivery.
Backer MV; Gaynutdinov TI; Aloise R; Przekop K; Backer JM
Protein Expr Purif; 2002 Dec; 26(3):455-61. PubMed ID: 12460770
[TBL] [Abstract][Full Text] [Related]
5. Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor.
Blankenberg FG; Mandl S; Cao YA; O'Connell-Rodwell C; Contag C; Mari C; Gaynutdinov TI; Vanderheyden JL; Backer MV; Backer JM
J Nucl Med; 2004 Aug; 45(8):1373-80. PubMed ID: 15299064
[TBL] [Abstract][Full Text] [Related]
6. Polyarginine as a multifunctional fusion tag.
Fuchs SM; Raines RT
Protein Sci; 2005 Jun; 14(6):1538-44. PubMed ID: 15930002
[TBL] [Abstract][Full Text] [Related]
7. Semisynthesis of ribonuclease A using intein-mediated protein ligation.
Arnold U; Hinderaker MP; Raines RT
ScientificWorldJournal; 2002 Jun; 2():1823-7. PubMed ID: 12806173
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a hybrid between ribonuclease A and bovine seminal ribonuclease--the basic surface, at 2.0 A resolution.
Vatzaki EH; Allen SC; Leonidas DD; Trautwein-Fritz K; Stackhouse J; Benner SA; Acharya KR
Eur J Biochem; 1999 Feb; 260(1):176-82. PubMed ID: 10091597
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
[TBL] [Abstract][Full Text] [Related]
10. Cysteine-containing fusion tag for site-specific conjugation of therapeutic and imaging agents to targeting proteins.
Backer MV; Levashova Z; Levenson R; Blankenberg FG; Backer JM
Methods Mol Biol; 2008; 494():275-94. PubMed ID: 18726580
[TBL] [Abstract][Full Text] [Related]
11. The flexibility of a distant loop modulates active site motion and product release in ribonuclease A.
Doucet N; Watt ED; Loria JP
Biochemistry; 2009 Aug; 48(30):7160-8. PubMed ID: 19588901
[TBL] [Abstract][Full Text] [Related]
12. A "dock and lock" approach to preparation of targeted liposomes.
Backer MV; Backer JM
Methods Mol Biol; 2010; 605():257-66. PubMed ID: 20072886
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional structure of human RNase 1 delta N7 at 1.9 A resolution.
Pous J; Mallorquí-Fernández G; Peracaula R; Terzyan SS; Futami J; Tada H; Yamada H; Seno M; de Llorens R; Gomis-Rüth FX; Coll M
Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):498-505. PubMed ID: 11264578
[TBL] [Abstract][Full Text] [Related]
14. Assembly of targeting complexes driven by a single-chain antibody.
Backer MV; Elliot J; Gaynutdinov TI; Backer JM
J Immunol Methods; 2004 Jun; 289(1-2):37-45. PubMed ID: 15251410
[TBL] [Abstract][Full Text] [Related]
15. Role of aspartic acid 121 in human pancreatic ribonuclease catalysis.
Gaur D; Batra JK
Mol Cell Biochem; 2005 Jul; 275(1-2):95-101. PubMed ID: 16335788
[TBL] [Abstract][Full Text] [Related]
16. Engineering ribonuclease A: production, purification and characterization of wild-type enzyme and mutants at Gln11.
delCardayré SB; Ribó M; Yokel EM; Quirk DJ; Rutter WJ; Raines RT
Protein Eng; 1995 Mar; 8(3):261-73. PubMed ID: 7479688
[TBL] [Abstract][Full Text] [Related]
17. The crystal structure of recombinant rat pancreatic RNase A.
Gupta V; Muyldermans S; Wyns L; Salunke DM
Proteins; 1999 Apr; 35(1):1-12. PubMed ID: 10090281
[TBL] [Abstract][Full Text] [Related]
18. A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis.
Harper JW; Vallee BL
Biochemistry; 1989 Feb; 28(4):1875-84. PubMed ID: 2719939
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
Johnson RJ; McCoy JG; Bingman CA; Phillips GN; Raines RT
J Mol Biol; 2007 Apr; 368(2):434-49. PubMed ID: 17350650
[TBL] [Abstract][Full Text] [Related]
20. Molecular vehicle for target-mediated delivery of therapeutics and diagnostics.
Gaidamakova EK; Backer MV; Backer JM
J Control Release; 2001 Jul; 74(1-3):341-7. PubMed ID: 11489516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
